DarioHealth Corp.

DRIO Nasdaq CIK: 0001533998

Company Information

Industry Surgical & Medical Instruments & Apparatus
SIC Code 3841
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 322 W 57TH ST. #33B, NEW YORK, NY, 10019
Mailing Address 322 W 57TH ST. #33B, NEW YORK, NY, 10019
Phone 972-4-770-6377
Fiscal Year End 1231
EIN 452973162

Recent SEC Filings

Form Type Date Filed Document
424B5 Prospectus supplement March 30, 2026 View on SEC
8-K Current report of material events March 30, 2026 View on SEC
10-K Annual financial report March 19, 2026 View on SEC
S-3 Shelf registration for future offerings March 19, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment February 13, 2026 View on SEC
8-K Current report of material events February 2, 2026 View on SEC
8-K Current report of material events January 29, 2026 View on SEC
S-3/A Shelf registration amendment December 29, 2025 View on SEC
DEF 14A Definitive proxy statement December 22, 2025 View on SEC
SCHEDULE 13G Passive beneficial ownership (>5%) December 16, 2025 View on SEC

Annual Reports

10-K March 19, 2026
  • Expanded digital mental health services and user base through the $200 million acquisition of Twill Inc. in September 2022.
  • Strong B2B2C model with partnerships (employers, health plans, providers) and strategic collaborations (drug companies, device makers) for broad customer reach and market expansion.
View Analysis

Related Companies

Companies in the same industry (SIC: 3841)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.